61 citations to 10.1128/AAC.01186-09 (Crossref Cited-By Service)
  1. V. L. Rusinov, V. N. Charushin, O. N. Chupakhin, “Biologically active azolo-1,2,4-triazines and azolopyrimidines”, Russ Chem Bull, 67, № 4, 2018, 573  crossref
  2. Aruna D. Balgi, Jun Wang, Daphne Y. H. Cheng, Chunlong Ma, Tom A. Pfeifer, Yoko Shimizu, Hilary J. Anderson, Lawrence H. Pinto, Robert A. Lamb, William F. DeGrado, Michel Roberge, Nicole M. Bouvier, “Inhibitors of the Influenza A Virus M2 Proton Channel Discovered Using a High-Throughput Yeast Growth Restoration Assay”, PLoS ONE, 8, № 2, 2013, e55271  crossref
  3. Konstantin V. Savateev, Pavel A. Slepukhin, Svetlana K. Kotovskaya, Valery N. Charushin, Vladimir L. Rusinov, Oleg N. Chupakhin, “Atom-efficient synthesis of hybrid molecules combining fragments of triazolopyrimidines and 3-ethoxycarbonyl-1-ethyl-6-fluoroquinolin-4(1H)-one through 1,2,3-triazole linker”, Chem Heterocycl Comp, 57, № 2, 2021, 143  crossref
  4. Tyler J. Ogorek, Jennifer E. Golden, “Advances in the Development of Small Molecule Antivirals against Equine Encephalitic Viruses”, Viruses, 15, № 2, 2023, 413  crossref
  5. T. S. Shestakova, I. A. Khalymbadzha, S. L. Deev, O. S. Eltsov, V. L. Rusinov, Z. O. Shenkarev, A. S. Arseniev, O. N. Chupakhin, “Synthesis of the [2H,15N]-labeled antiviral drug “triazavirine””, Russ Chem Bull, 60, № 4, 2011, 729  crossref
  6. Xiaoke Wu, Kaijiang Yu, Yongchen Wang, Wanhai Xu, Hongli Ma, Yan Hou, Yue Li, Benzhi Cai, Liying Zhu, Min Zhang, Xiaoli Hu, Jingshu Gao, Yu Wang, Huichao Qin, Wenjie Wang, Mingyan Zhao, Xia Wu, Yong Zhang, Lu Li, Kang Li, Zhimin Du, Ben Willem J. Mol, Baofeng Yang, “Efficacy and Safety of Triazavirin Therapy for Coronavirus Disease 2019: A Pilot Randomized Controlled Trial”, Engineering, 6, № 10, 2020, 1185  crossref
  7. Alexey V. Shvetsov, Yana A. Zabrodskaya, Peter A. Nekrasov, Vladimir V. Egorov, “Triazavirine supramolecular complexes as modifiers of the peptide oligomeric structure”, Journal of Biomolecular Structure and Dynamics, 36, № 10, 2018, 2694  crossref
  8. S. V. Chepur, A. V. Smirnova, A. N. Kirienko, I. A. Myasnikova, B. A. Kanevsky, P. V. Sorokin, “Study of Riamilovir Activity Against SARS-CoV-2 Infection In Syrian Hamsters”, A&Ch, 66, № 7-8, 2021, 13  crossref
  9. Sunny Kumar, Malini Basu, Pratyasha Ghosh, Uttam Pal, Mrinal K. Ghosh, “COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery”, Genes & Diseases, 10, № 4, 2023, 1402  crossref
  10. S. M. Ivanov, Е. I. Tuzharov, N. G. Kolotyrkina, “Synthesis of 7-Amino-3-tert-butyl-2-alkylthiopyrrolo[1,2-b][1,2,4]triazine-6-carboxylates”, Russ J Gen Chem, 91, № 12, 2021, 2453  crossref
Предыдущая
1
2
3
4
5
6
7
Следующая